Key result
The 2019 ESC guidelines provided a more accurate risk assessment for obstructive coronary artery disease compared to the 2016 NICE guidelines, demonstrating an overall net reclassification improvement of 27.31%.
Why the study?
Low-risk individuals rarely benefit from noninvasive testing and women have a lower prevalence of obstructive CAD, prompting a comparison of sex-specific performance between NICE and ESC guidelines in stable chest pain outpatients.
Does the 2019 ESC guideline risk assessment improve the prediction of obstructive CAD compared to the 2016 NICE guideline in symptomatic outpatients?
Observational (n=542)
No
Does the 2019 ESC guideline risk assessment improve the prediction of obstructive CAD compared to the 2016 NICE guideline in symptomatic outpatients?
The 2019 ESC guidelines provide a more accurate risk assessment for obstructive CAD than the 2016 NICE guidelines, reducing inappropriate testing in women while increasing appropriate testing in men.
Answers are grounded in this paper and cite their sources.
Sex-specific guideline performance in stable chest pain warrants caution in low-risk women; leaves open optimal strategy pending validation.
Background Low-risk individuals are unlikely to benefit from noninvasive testing, and women tend to have a lower prevalence of obstructive coronary artery disease (CAD). This study compared the performance of two current guidelines that differ by sex to assess stable chest pain outpatients, including symptom-based (2016 National Institute for Health and Care Excellence, NICE) and risk-based strategies (2019 European Society of Cardiology, ESC). Methods A total of 542 men and women outpatients referred for coronary computed tomography angiography (CCTA) at a single-centre were retrospectively included in this study. A risk assessment was calculated for each outpatient according to the NICE and ESC guidelines. Patients were classified into low-risk and high-risk groups according to each strategy. The presence of obstructive coronary artery disease was the endpoint. Net reclassification improvement (NRI) was used to assess the performance of the two strategies. Results The 2016 NICE guidelines classified 29.39% of women and 34.60% of men into the low-risk group. The 2019 ESC guidelines classified 55.56% of women and 28.14% of men into the low-risk group. The 2019 ESC guidelines had a higher predictive value for coronary artery disease compared to the 2016 NICE guidelines, with a positive NRI in men (15.55%) and women (36.59%) respectively. Conclusion The 2019 ESC guidelines offered a more accurate calculation of risk assessment than the 2016 NICE guidelines. Patient sex influenced applying the recent ESC guidelines, which would result in a significant decrease in inappropriate testing of women but an increase in appropriate noninvasive testing of men.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2021) conducted an observational in Stable chest pain suspected of coronary artery disease (n=542). 2019 ESC guidelines risk assessment strategy vs. 2016 NICE guidelines risk assessment strategy was evaluated on Net reclassification improvement (NRI) for the presence of obstructive coronary artery disease (NRI 27.31%, p=<0.05). The 2019 ESC guidelines provided a more accurate risk assessment for obstructive coronary artery disease compared to the 2016 NICE guidelines, demonstrating an overall net reclassification improvement of 27.31%.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: